BUND FINANCE

BUND FINANCE › Stocks › JNJ

Johnson & Johnson (JNJ)

NYSE · Stock price, chart and technical analysis

US$272.70-6.00 (-2.15%)

Data from Financial Modeling Prep · Nov 18, 2026, 4:00 PM New York time · may be delayed

Open the live chartSee Technicals⏱ Analyze entryQuarterly earnings📅 See in calendar💬 Explain this move⇄ ComparePractice in the Simulator

Key stats

Previous closeUS$278.70
OpenUS$275.55
Day rangeUS$272.58 – US$278.70
52-week rangeUS$199.38 – US$290.25
Market capUS$656.47B
Volume7.93M
50-day averageUS$267.20
200-day averageUS$250.30
Beta0.24
Last dividend per shareUS$5.28

Quick technical read

This describes price action; it is not a recommendation. The app also calculates RSI, MACD, the entry setup and 30+ indicators. How we calculate it

Fundamentals Annual

Fiscal year20212022202320242025
RevenueUS$78.7BUS$80.0BUS$85.2BUS$88.8BUS$94.2B
Net incomeUS$20.9BUS$17.9BUS$35.2BUS$14.1BUS$26.8B
EPS (diluted)7.816.7313.725.7911.03
Gross margin70.3%69.3%68.8%69.1%67.9%
Operating margin26.6%26.3%27.5%24.9%27.2%
Net margin26.5%22.4%41.3%15.8%28.5%
Free cash flowUS$19.8BUS$17.2BUS$18.2BUS$19.8BUS$19.7B
Total debtUS$33.8BUS$39.6BUS$29.3BUS$36.6BUS$47.9B
CashUS$14.5BUS$12.9BUS$21.9BUS$24.1BUS$19.7B

Compound annual growth: revenue 4.6% · net income 6.5% (4 years).

Valuation: today, its history and its sector

Today5-year averageSector median (Healthcare)
P/E41.3x20.4x27.1x
EV / EBITDA25.5x16.1x16.5x
Operating margin25.2%—3.6%
Net margin16.2%—-0.0%
Debt / equity1.42—0.58

Source: annual financial statements from Financial Modeling Prep. “Today” uses the current price and the last 4 quarters. The sector median uses U.S. companies above US$300M market cap. A multiple above or below its history or sector is not a recommendation.

About Johnson & Johnson

SectorHealthcare
IndustryDrug Manufacturers - General
CountryUS
CEOJoaquin Duato
Employees141,700
IPO date1962-01-02

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

www.jnj.com

Other stocks on BUND FINANCE

Not financial advice. BUND FINANCE publishes general information for educational purposes. Investing involves risk, including loss of capital. Legal notice